S2Medical AB (S2M) — Cash Flow Reinvestment Rate
S2Medical AB (S2M) has a Cash Flow Reinvestment Rate of 1.56x as of June 2025, reinvesting Skr2.01 Million (capex Skr1.01 Million plus investments Skr-1.01 Million) from operating cash flow of Skr1.29 Million. See S2M cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
S2Medical AB Cash Flow Reinvestment Rate (2024–2025)
Historical reinvestment intensity for S2Medical AB across 2 annual periods. For the full cash flow conversion analysis, see S2Medical AB cash conversion from operations.
Annual Cash Flow Reinvestment Rate for S2Medical AB (2024–2025)
Year-by-year capital reinvestment analysis for S2Medical AB. See how financially flexible is S2Medical AB to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | Skr675.00K | Skr675.00K | Skr675.00K | ▲ +296.8% |
| 2024 | 0.25x | Skr1.27 Million | Skr5.03 Million | Skr634.00K | — |